Skip to main content
Homepage of ProQR
  • We are ProQR
    • About ProQR Therapeutics
    • Founding story
    • Leadership
    • Careers
      • Vacancies
    • Contact
    • Events
  • Science & Pipeline
    • Pipeline
      • Sepofarsen (CEP290 LCA10)
      • QR-421a (USH2A RP)
      • QR-1123 (RHO RP)
      • QR-504a (TCF4 FECD)
    • Presentations & Publications
    • RNA therapy
      • Axiomer technology
  • Patients & Community
    • Blogs, Stories & News
    • What is a clinical trial?
      • Illuminate Ph2/3 trial (CEP290 LCA10)
      • Brighten pediatric trial (CEP290 LCA10)
      • Stellar Ph1/2 trial (USH2A RP)
      • Aurora Ph1/2 trial (RHO RP)
      • Fuchs Focus Ph1 trial (TCF4 FECD)
    • Inherited retinal diseases
      • Leber congenital amaurosis
      • Retinitis pigmentosa
      • Usher syndrome
    • The importance of genetic testing
      • My Retina Tracker program
    • Eye Connect newsletter
    • Expanded access policy
  • Health Professionals
    • Clinical research
    • Events
    • Expert Eyes newsletter
    • Expert Perspectives series
    • HCP resources
      • IRDs and assessment
      • Patient journey and referral
      • Genetic testing
      • Intravitreal injection
  • Investors & Media
    • Press Releases
    • Events
    • Email alerts
    • Corporate presentation
    • Share performance
    • Financial information
    • Corporate governance
    • Analysts
Events

The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2021

Event info

Add The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2021 to calender
Healthcare professionals
May 02 2021 to 06 May

The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2021

ProQR to participate in the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2021.

Follow us:

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • SoundCloud
  • Contact
  • Disclaimer
  • Privacy
© 2021 ProQR Therapeutics. All Rights Reserved.